20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Coronary Artery Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bass, A; Caughey, M; Edin, ML; Ellis, K; Hinderliter, AL; Lee, CR; Lih, FB; Schuck, RN; Simmons, BP; Steele, S; Stouffer, GA; Theken, KN; Tomer, KB; Tran, B; Wu, MC; Zeldin, DC | 1 |
| Bass, A; Edin, ML; Ellis, K; Hinderliter, AL; Lee, CR; Lih, FB; Poloyac, SM; Schuck, RN; Stouffer, GA; Theken, KN; Tomer, KB; Tran, B; Wu, MC; Zeldin, DC | 1 |
2 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Coronary Artery Disease
| Article | Year |
|---|---|
Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients.
Topics: Aged; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Coronary Artery Disease; Cross-Sectional Studies; Cytochrome P-450 Enzyme System; Eicosanoids; Endothelium, Vascular; Epoxide Hydrolases; Female; Humans; Hydroxyeicosatetraenoic Acids; Inflammation; Male; Middle Aged; Phenotype; Prognosis | 2013 |
Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
Topics: 8,11,14-Eicosatrienoic Acid; Age Factors; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Eicosanoids; Epoxide Hydrolases; Female; Humans; Hydroxyeicosatetraenoic Acids; Hydroxylation; Male; Middle Aged; North Carolina; Obesity; Regression Analysis; Risk Assessment; Risk Factors; Severity of Illness Index; Smoking; Tandem Mass Spectrometry | 2012 |